Brief: Basilea Pharmaceutica Shareholders Approve All Board Proposals At 2026 AGM
April 15 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S: BASILEA PHARMACEUTICA - SHAREHOLDERS APPROVE ALL BOARD PROPOSALS AT 2026 AGM Source text: ID:nGNXbqZl7S Further company coverage: BSLN.S ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments